18.08.2016 Views

Campaigns to Curb High Prevalence of Obesity and Heart Diseases to Bolster Demand for Phytosterols, says TMR

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Transparency Market<br />

Research<br />

Phy<strong>to</strong>sterols Market by Type - Global Industry Analysis, Size,<br />

Share, Growth, Trends <strong>and</strong> Forecast 2015 - 2021<br />

Published Date<br />

28-09-2015<br />

84 Page Report<br />

Buy Now<br />

Request Sample<br />

Press Release<br />

<strong>Campaigns</strong> <strong>to</strong> <strong>Curb</strong> <strong>High</strong> <strong>Prevalence</strong> <strong>of</strong> <strong>Obesity</strong> <strong>and</strong> <strong>Heart</strong> <strong>Diseases</strong> <strong>to</strong><br />

<strong>Bolster</strong> Dem<strong>and</strong> <strong>for</strong> Phy<strong>to</strong>sterols, <strong>says</strong> <strong>TMR</strong><br />

Transparency Market Research<br />

State Tower,<br />

90, State Street, Suite 700.<br />

Albany, NY 12207<br />

United States<br />

www.transparencymarketresearch.com<br />

sales@transparencymarketresearch.com


Phy<strong>to</strong>sterols Market<br />

REPORT DESCRIPTION<br />

Recent technological advancements have made phy<strong>to</strong>sterols fit <strong>for</strong> commercial extraction. In the last few<br />

years dem<strong>and</strong> <strong>for</strong> phy<strong>to</strong>sterols has considerably increased across developed countries as they witness a<br />

high incidence <strong>of</strong> heart diseases. Despite being structurally quite similar <strong>to</strong> cholesterols, phy<strong>to</strong>sterols have<br />

cholesterol lowering properties. The knowledge regarding the same has been fuelling their dem<strong>and</strong> across<br />

countries with high prevalence <strong>of</strong> obesity, which is a primary cause <strong>of</strong> heart diseases.<br />

View exclusive Global strategic Business<br />

report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=747<br />

However, as per Transparency Market Research (<strong>TMR</strong>), the phy<strong>to</strong>sterols market is yet <strong>to</strong> establish a strong<br />

footprint across developing countries. The inadequate awareness about the intrinsic health benefits <strong>of</strong><br />

phy<strong>to</strong>sterols limits scope <strong>for</strong> the market’s growth across these regions.<br />

Nevertheless, the prospects <strong>for</strong> the market in Asia Pacific seem very lucrative, as India <strong>and</strong> China witness a<br />

rising incidence <strong>of</strong> coronary heart diseases. Spurred by these fac<strong>to</strong>rs, the global phy<strong>to</strong>sterols market is<br />

expected <strong>to</strong> report a CAGR <strong>of</strong> 10% between 2015 <strong>and</strong> 2021. The market is expected <strong>to</strong> reach US$926.7 mn<br />

in 2021 from a valuation <strong>of</strong> US$473.8 in 2014.<br />

Use <strong>of</strong> Phy<strong>to</strong>sterols as Food Ingredients <strong>to</strong> Increase Rapidly<br />

Phy<strong>to</strong>sterols exhibit diverse applications across industries such as pharmaceuticals, cosmetics, <strong>and</strong> food<br />

<strong>and</strong> beverages. In 2014, the use <strong>of</strong> phy<strong>to</strong>sterols as food ingredients held the largest market share in terms<br />

<strong>of</strong> value. According <strong>to</strong> <strong>TMR</strong>, dem<strong>and</strong> from food ingredients segment accounted <strong>for</strong> over 50.45% <strong>of</strong> the<br />

market in 2014. The rising use <strong>of</strong> phy<strong>to</strong>sterols as food ingredients due <strong>to</strong> their cholesterol lower properties<br />

is expected <strong>to</strong> fuel dem<strong>and</strong> from the segment during the <strong>for</strong>ecast period. Manufacturers operating in the<br />

food <strong>and</strong> beverages industry are including phy<strong>to</strong>sterols in many <strong>of</strong> their food products <strong>to</strong> cater <strong>to</strong> their<br />

consumers’ health requirements.<br />

However, during the <strong>for</strong>ecast period dem<strong>and</strong> from the pharmaceuticals segment is expected <strong>to</strong> rise at the<br />

highest rate. The increasing awareness among consumers about the benefits <strong>of</strong> phy<strong>to</strong>sterols in reducing<br />

the risk <strong>of</strong> heart diseases is fuelling dem<strong>and</strong> from the segment. Furthermore, the incidence <strong>of</strong> heart<br />

ailments is expected <strong>to</strong> increase in India <strong>and</strong> China, thereby escalating phy<strong>to</strong>sterols dem<strong>and</strong> from these<br />

countries.<br />

Besides this, the cosmetics industry is a niche segment in the global phy<strong>to</strong>sterols market. However, the<br />

dem<strong>and</strong> from this segment is also expected <strong>to</strong> rise in the <strong>for</strong>thcoming years. The rising disposable income<br />

<strong>of</strong> consumers will be the primary fac<strong>to</strong>r bolstering use <strong>of</strong> phy<strong>to</strong>sterols in the cosmetics industry.<br />

Europe <strong>and</strong> North America Emerge as Most Lucrative Markets <strong>for</strong> Phy<strong>to</strong>sterols<br />

Geographically, Europe accounted <strong>for</strong> 40.27% <strong>of</strong> the dem<strong>and</strong> witnessed in the global phy<strong>to</strong>sterols market<br />

in 2014. The increasing application <strong>of</strong> phy<strong>to</strong>sterols across end-use industries such as pharmaceuticals,<br />

cosmetics, <strong>and</strong> food <strong>and</strong> beverages has been fuelling dem<strong>and</strong> <strong>for</strong> phy<strong>to</strong>sterols from the region. Besides<br />

Transparency Market Research<br />

2


Phy<strong>to</strong>sterols Market<br />

this, the increasing incidence <strong>of</strong> coronary heart diseases is a key fac<strong>to</strong>r fuelling dem<strong>and</strong> <strong>for</strong> phy<strong>to</strong>sterols<br />

from Europe <strong>and</strong> North America, alike.<br />

The high prevalence <strong>of</strong> obesity has emerged as a major cause <strong>of</strong> concern <strong>for</strong> policymakers in North<br />

America. Since phy<strong>to</strong>sterols are cholesterol reducing agents, they are considered ideal <strong>for</strong> preventing<br />

increased cholesterol level in human body. Their dem<strong>and</strong> is thus expected <strong>to</strong> increase substantially across<br />

these developed regions through the <strong>for</strong>ecast period.<br />

In contrast, the lack <strong>of</strong> awareness about the benefits <strong>of</strong> phy<strong>to</strong>sterols is limiting the market’s expansion<br />

across Asia Pacific <strong>and</strong> Rest <strong>of</strong> the World (RoW). However, <strong>TMR</strong>, expects, the phy<strong>to</strong>sterols market in Rest <strong>of</strong><br />

the World <strong>to</strong> rise at the highest pace during the <strong>for</strong>ecast period. The rising disposable income <strong>of</strong> consumers<br />

in RoW has led them <strong>to</strong> upgrade their lifestyle. This will subsequently boost prospects <strong>for</strong> the phy<strong>to</strong>sterols<br />

market.<br />

Some <strong>of</strong> key players operating in the market are Archer Daniels Midl<strong>and</strong> Co., BASF SE, Bunge Ltd, Triple<br />

Crown AB, E.I. DuPont De Nemours, Pharmachem Labora<strong>to</strong>ries, <strong>and</strong> others.<br />

TABLE OF CONTENT<br />

Chapter 1 Preface<br />

1.1 Report Description<br />

1.2 Market segmentation<br />

1.2.1 Global phy<strong>to</strong>sterols market segmentation, by product type, application <strong>and</strong> by geography<br />

1.3 Research scope<br />

1.4 Research Methodology<br />

Chapter 2 Executive Summary<br />

2.1 Global phy<strong>to</strong>sterols market revenue <strong>and</strong> volume, 2014 - 2021 (USD Million <strong>and</strong> Million Tons)<br />

2.2 Global phy<strong>to</strong>sterols market snapshot<br />

Chapter 3 Global Phy<strong>to</strong>sterols Market - Industry Analysis<br />

3.1 Introduction<br />

3.2 Market Drivers<br />

Transparency Market Research<br />

3


Phy<strong>to</strong>sterols Market<br />

3.2.1 Drivers <strong>for</strong> Phy<strong>to</strong>sterols Market: Impact Analysis<br />

3.2.2 Rising incidence <strong>of</strong> deaths due <strong>to</strong> cardiovascular diseases<br />

3.2.3 Health benefits <strong>of</strong>fered by phy<strong>to</strong>sterols<br />

3.2.4 Variety <strong>of</strong> end-use applications<br />

3.2.5 Regulating bodies approving the usage <strong>of</strong> phy<strong>to</strong>sterols<br />

3.3 Market Restraints<br />

3.3.1 Restraints <strong>for</strong> the Global Phy<strong>to</strong>sterols Market: Impact Analysis<br />

3.3.2 Lack <strong>of</strong> awareness in developing countries<br />

3.3.3 Availability <strong>of</strong> similar functional products<br />

3.4 Market Opportunities<br />

3.4.1 Technological advancement<br />

3.4.2 Growth potential in developing regions<br />

3.5 Market Trend Analysis<br />

3.6 Value Chain Analysis<br />

3.7 Market Attractiveness Analysis<br />

3.8 Key players in the global phy<strong>to</strong>sterols market<br />

Chapter 4 Global Phy<strong>to</strong>sterols Market by Product Type, 2015–2021<br />

4.1 Overview<br />

4.2 B-si<strong>to</strong>sterol<br />

4.3 Campesterol<br />

4.4 Stigmasterol<br />

Transparency Market Research<br />

4


Phy<strong>to</strong>sterols Market<br />

4.5 Others<br />

Chapter 5 GlobalPhy<strong>to</strong>sterols Market Analysisby Application, 2014–2021<br />

5.1 Overview<br />

5.2 Food Ingredients<br />

5.3 Pharmaceuticals<br />

5.4 Cosmetics<br />

Chapter 6 Global Phy<strong>to</strong>sterols Market Analysis by Geography, 2015–2021<br />

6.1 Overview<br />

6.2 North America<br />

6.2.1 North America Phy<strong>to</strong>sterols Market Revenue/Volume, by Product Type (2014–2021) (USD<br />

Million/Million Tons)<br />

6.2.2 North America Phy<strong>to</strong>sterols Market Revenue <strong>and</strong> Volume, by Country (USD Million/Million <strong>to</strong>ns)<br />

6.2.3 U.S.<br />

6.2.4 Canada<br />

6.2.5 Mexico<br />

6.3 Europe<br />

Tons)<br />

6.3.1 Europe Phy<strong>to</strong>sterols Market Revenue/Volume, by Product Type (2014–2021) (USD Million/Million<br />

6.3.2 Europe Phy<strong>to</strong>sterols Market Revenue <strong>and</strong> Volume, by Country (USD Million/Million Ton)<br />

6.3.3 U.K.<br />

6.3.4 Germany<br />

6.3.5 France<br />

Transparency Market Research<br />

5


Phy<strong>to</strong>sterols Market<br />

6.3.6 Italy<br />

6.3.7 Rest <strong>of</strong> Europe<br />

6.4 Asia Pacific<br />

6.4.1 Asia Pacific Phy<strong>to</strong>sterols Market Revenue/Volume, by Type (2014–2021) (USD Million/ Million Tons)<br />

Tons)<br />

6.4.2 Asia Pacific Phy<strong>to</strong>sterols Market Revenue/Volume, by Country (2014–2021) (USD Million/Million<br />

6.4.3 India<br />

6.4.4 China<br />

6.4.5 Japan<br />

6.4.6 Rest <strong>of</strong> APAC<br />

6.5 Rest <strong>of</strong> the World (RoW)<br />

6.5.1 Rest <strong>of</strong> the World Phy<strong>to</strong>sterols Market Revenue/Volume, by Type (2014–2021) (USD Million/Million<br />

Tons)<br />

6.5.2 Rest <strong>of</strong> the World Phy<strong>to</strong>sterols Market Revenue/Volume, by Country (2014–2021) (USD<br />

Million/Million Tons)<br />

6.5.3 Latin America<br />

6.5.4 Middle East<br />

6.5.5 Africa<br />

Chapter 7 Company Pr<strong>of</strong>iles<br />

7.1 Archer Daniels Midl<strong>and</strong>s Co.<br />

7.2 BASF SE<br />

7.3 Bunge Ltd<br />

Transparency Market Research<br />

6


Phy<strong>to</strong>sterols Market<br />

7.4 Cargill Incorporated<br />

7.5 Pharmachem Labora<strong>to</strong>ries<br />

7.6 Unilever plc<br />

7.7 E.I. DuPont De Nemours<br />

7.8 Raisio plc<br />

7.9 Arboris LLC<br />

7.10 Triple Crown AB<br />

About Us<br />

Transparency Market Research is a market intelligence company providing global business in<strong>for</strong>mation<br />

reports <strong>and</strong> services. Our exclusive blend <strong>of</strong> quantitative <strong>for</strong>ecasting <strong>and</strong> trends analysis provides <strong>for</strong>wardlooking<br />

insight <strong>for</strong> thous<strong>and</strong>s <strong>of</strong> decision makers.<br />

We are privileged with highly experienced team <strong>of</strong> Analysts, Researchers <strong>and</strong> Consultants, who use<br />

proprietary data sources <strong>and</strong> various <strong>to</strong>ols <strong>and</strong> techniques <strong>to</strong> gather, <strong>and</strong> analyze in<strong>for</strong>mation. Our<br />

business <strong>of</strong>ferings represent the latest <strong>and</strong> the most reliable in<strong>for</strong>mation indispensable <strong>for</strong> businesses <strong>to</strong><br />

sustain a competitive edge.<br />

Contact<br />

Transparency Market Research<br />

90 State Street,<br />

Suite 700,<br />

Albany<br />

NY - 12207<br />

United States<br />

Tel: +1-518-618-1030<br />

USA - Canada Toll Free 866-552-3453<br />

Email: sales@transparencymarketresearch.com<br />

Website: http://www.transparencymarketresearch.com/<br />

Transparency Market Research<br />

7

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!